Trends in prescription opioid use in pediatric emergency department patients

Maryann Mazer-Amirshahi1, Peter M Mullins, Irit R Rasooly

  • 1From the *Department of Emergency Medicine, The George Washington University; †The George Washington University School of Medicine and Health Sciences; ‡Department of Pediatrics, The George Washington University; and §Department of Clinical Pharmacology, Children's National Medical Center, Washington, DC.

Insights

Opioid prescribing for pediatric pain in US emergency departments rose from 2001-2010, especially for adolescents. This trend highlights the need for careful pain management to balance relief and opioid risks.

Area of Science:

  • Pediatric Emergency Medicine
  • Pain Management
  • Pharmacology

Background:

  • Increased focus on pain management in emergency departments (EDs).
  • Growing concerns about the abuse potential of prescription opioids.
  • Need to understand trends in pediatric opioid prescribing.

Purpose of the Study:

  • To describe trends in opioid prescribing for pediatric patients in US EDs over a decade (2001-2010).
  • To analyze specific opioid types and non-opioid pain reliever use.
  • To stratify findings by age, diagnosis, and Drug Enforcement Agency (DEA) schedule.

Main Methods:

  • Analysis of the 2001-2010 National Hospital Ambulatory Medical Care Survey data.
  • Identification of pain-related ED visits in pediatric patients (≤19 years).
  • Tabulation of opioid analgesic administration/prescription, stratified by age, year, and opioid type (codeine, hydrocodone, hydromorphone, morphine, oxycodone).

Main Results:

  • Overall opioid use in pediatric ED pain visits increased from 11.2% to 14.5% (2001-2010).
  • Use of DEA Schedule II agents doubled (3.6% to 7.0%), with hydrocodone being most frequent.
  • Increased opioid use was most pronounced in adolescent patients; non-opioid use remained stable.

Conclusions:

  • Opioid use for pediatric pain in EDs significantly increased between 2001 and 2010.
  • Adolescents showed the most dramatic increase in opioid prescribing.
  • ED providers must balance effective pain relief with minimizing opioid-related adverse effects.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K